Common mitochondrial polymorphisms as risk factor for endometrial cancer

International Archives of Medicine

Volumn 2, Issue 1, 2009, Pages

  Czarnecka, Anna M ^a,b   Klemba, Aleksandra ^a   Semczuk, Andrzej ^c   Plak, Katarzyna ^a   Marzec, Barbara ^d   Krawczyk, Tomasz ^e   Kofler, Barbara ^f   Golik, Pawel ^a,g   Bartnik, Ewa ^a,g  

^a UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d Lublin University   (Poland)

^e Polish Mothers Health Center Research Institute   (Poland)

^f PARACELSUS MEDICAL UNIVERSITY   (Austria)

^g INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MITOCHONDRION; OVARIECTOMY; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

EID: 77953380358     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-2-33     Document Type: Article

References (98)

1. Endometrial cancer. TP Canavan NR Doshi, Am Fam Physician 1999 59 11 3069 3077 10392590
2. Endometrial carcinoma. BM Ronnett RJ Zaino LH Ellenson RJ Kurman, Blaustein's Pathology of the Female Genital Tract New York, Berlin, Heidelberg: Springer, Kurman RJ, 2002 501 559
3. Estimates of the cancer incidence and mortality in Europe in 2006. J Ferlay P Autier M Boniol M Heanue M Colombet P Boyle, Ann Oncol 2007 18 3 581 592 10.1093/annonc/mdl498 17287242 (Pubitemid 46359643)
4. SEER Cancer Statistics Review. L Ries D Melbert M Krapcho A Mariotto B Miller E Feuer L Clegg M Horner N Howlader M Eisner, et al. Bethesda: National Cancer Institute 2007
5. Uterine cancer. NF Hacker, Practical Gynecologic Oncology Philadelphia: Lippincott Williams & Wilkins, Berek JS, Hacker NF, 2004 397 442
6. [Molecular biology of endometrial carcinoma]. A Klemba W Kukwa E Bartnik T Krawczyk A Scinska P Golik AM Czarnecka, Postepy Hig Med Dosw (Online) 2008 62 420 432 18772847
7. Radiologic staging in patients with endometrial cancer: a meta-analysis. K Kinkel Y Kaji KK Yu MR Segal Y Lu CB Powell H Hricak, Radiology 1999 212 3 711 718 10478237
8. Staging quality is related to the survival of women with endometrial cancer: a Scottish population based study. Deficient surgical staging and omission of adjuvant radiotherapy is associated with poorer survival of women diagnosed with endometrial cancer in Scotland during 1996 and 1997. SC Crawford L De Caestecker CR Gillis D Hole JA Davis G Penney NA Siddiqui, Br J Cancer 2002 86 12 1837 1842 10.1038/sj.bjc.6600358 12085172
9. Gynecologic malignancies. BP Whitcomb, Surg Clin North Am 2008 88 2 301 317 10.1016/j.suc.2008.01.004 18381115
10. Novel molecular profiles of endometrial cancer-new light through old windows. A Doll M Abal M Rigau M Monge M Gonzalez S Demajo E Colas M Llaurado H Alazzouzi J Planaguma, et al. J Steroid Biochem Mol Biol 2008 108 3-5 221 229 10.1016/j.jsbmb.2007.09.020 18061438
11. Molecular and pathologic aspects of endometrial carcinogenesis. JL Hecht GL Mutter, J Clin Oncol 2006 24 29 4783 4791 10.1200/JCO.2006.06.7173 17028294
12. Mitochondrial mutations in cancer. M Brandon P Baldi DC Wallace, Oncogene 2006 25 34 4647 4662 10.1038/sj.onc.1209607 16892079
13. Mitochondrial DNA haplogroups influence AIDS progression. SL Hendrickson HB Hutcheson E Ruiz-Pesini JC Poole J Lautenberger E Sezgin L Kingsley JJ Goedert D Vlahov S Donfield, et al. AIDS 2008 22 18 2429 2439 10.1097/QAD.0b013e32831940bb 19005266
14. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. DC Wallace, Annu Rev Genet 2005 39 359 407 10.1146/annurev.genet.39.110304.095751 16285865
15. Mitochondrial DNA mutations in human neoplasia. A Czarnecka P Golik E Bartnik, J Appl Genet 2006 47 1 67 78 16424612
16. Mitochondrial DNA Mutations in Tumors. AM Czarnecka E Bartnik, Cellular Respiration and Carcinogenesis New York City: Humana Press, Apte SP, Sarangarajan R, 2009 1 12
17. Methodology For Mitochondrial DNA Research In Oncology: Goals And Pitfalls. AM Czarnecka T Krawczyk JS Czarnecki W Kukwa A ciska A Ribbene R Lo Verde A Sunseri G Peri, ARS Medica Tomitana 2008 XIV 1 48 64
18. Cancer as a "Mitochondriopathy". AM Czarnecka A Marino Gammazza V Di Felice G Zummo F Cappello, J Cancer Mol 2007 3 71 79
19. Breast cancer as a mitochondrial disorder (Review). K Plak AM Czarnecka T Krawczyk P Golik E Bartnik, Oncol Rep 2009 21 4 845 851 19287978
20. Glucose metabolism and cancer. RJ Shaw, Curr Opin Cell Biol 2006 18 6 598 608 10.1016/j.ceb.2006.10.005 17046224
21. On respiratory impairment in cancer cells. O Warburg, Science 1956 124 3215 269 270 13351639
22. Mitochondrial DNA medicine. S DiMauro, Biosci Rep 2007 27 1-3 5 9 10.1007/s10540-007-9032-5 17484047
23. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. JA Smeitink M Zeviani DM Turnbull HT Jacobs, Cell Metab 2006 3 1 9 13 10.1016/j.cmet.2005.12.001 16399500
24. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. AM Czarnecka T Krawczyk M Zdrozny J Lubinski RS Arnold W Kukwa A Scinska P Golik E Bartnik JA Petros, Breast Cancer Res Treat 2009 19266278
25. [Mitochondrial DNA mutations in the pathogenesis in the head and neck squamous cell carcinoma]. G Pietka W Kukwa E Bartnik A Scinska AM Czarnecka, Otolaryngol Pol 2008 62 2 158 164 18637439
26. [The impact of mtDNA mutations on proteins structure in selected types of cancer]. K Plak W Kukwa E Bartnik P Golik A Scinska T Krawczyk AM Czarnecka, Postepy Biochem 2008 54 2 151 160 18807926
27. Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus. S Datta M Majumder NK Biswas N Sikdar B Roy, Cancer 2007 110 9 1991 1999 10.1002/cncr.23016 17886251
28. Mitochondrial DNA polymorphism and risk of cancer. KK Singh M Kulawiec, Methods Mol Biol 2009 471 291 303 full-text 19109786
29. mtDNA mutations increase tumorigenicity in prostate cancer. JA Petros AK Baumann E Ruiz-Pesini MB Amin CQ Sun J Hall S Lim MM Issa WD Flanders SH Hosseini, et al. Proc Natl Acad Sci USA 2005 102 3 719 724 10.1073/pnas. 0408894102 15647368
30. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. PK Ha BC Tong WH Westra M Sanchez-Cespedes P Parrella M Zahurak D Sidransky JA Califano, Clin Cancer Res 2002 8 7 2260 2265 12114429
31. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. MS Fliss H Usadel OL Caballero L Wu MR Buta SM Eleff J Jen D Sidransky, Science 2000 287 5460 2017 2019 10.1126/science.287.5460.2017 10720328
32. Comparison between the Polish population and European populations on the basis of mitochondrial morphs and haplogroups. J Piechota K Tonska M Nowak D Kabzinska A Lorenc E Bartnik, Acta Biochim Pol 2004 51 4 883 895 15625560
33. mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. M Ingman U Gyllensten, Nucleic Acids Res 2006 34 Database 749 751 10.1093/nar/gkj010 16381973
34. An enhanced MITOMAP with a global mtDNA mutational phylogeny. E Ruiz-Pesini MT Lott V Procaccio JC Poole MC Brandon D Mishmar C Yi J Kreuziger P Baldi DC Wallace, Nucleic Acids Res 2007 35 Database 823 828 10.1093/nar/gkl927 17178747
35. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. I Campbell, Stat Med 2007 26 19 3661 3675 10.1002/sim.2832 17315184
36. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. MS Pepe H Janes G Longton W Leisenring P Newcomb, Am J Epidemiol 2004 159 9 882 890 10.1093/aje/kwh101 15105181
37. Methodology For Mitochondrial DNA Research In Oncology: Goals And Pitfalls. AM Czarnecka T Krawczyk JS Czarnecki W Kukwa A Ścińska A Ribbene R Lo Verde A Sunseri G Peri, ARS Medica Tomitana 2008 XIV 1 (52) 48 64
38. Sequence and organization of the human mitochondrial genome. S Anderson AT Bankier BG Barrell MH de Bruijn AR Coulson J Drouin IC Eperon DP Nierlich BA Roe F Sanger, et al. Nature 1981 290 5806 457 465 10.1038/290457a0 7219534
39. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. RM Andrews I Kubacka PF Chinnery RN Lightowlers DM Turnbull N Howell, Nat Genet 1999 23 2 147 10.1038/13779 10508508
40. Phylogenetic network for European mtDNA. S Finnila MS Lehtonen K Majamaa, Am J Hum Genet 2001 68 6 1475 1484 10.1086/320591 11349229
41. The emerging tree of West Eurasian mtDNAs: a synthesis of control-region sequences and RFLPs. V Macaulay M Richards E Hickey E Vega F Cruciani V Guida R Scozzari B Bonne-Tamir B Sykes A Torroni, Am J Hum Genet 1999 64 1 232 249 10.1086/302204 9915963
42. Classification of European mtDNAs from an analysis of three European populations. A Torroni K Huoponen P Francalacci M Petrozzi L Morelli R Scozzari D Obinu ML Savontaus DC Wallace, Genetics 1996 144 4 1835 1850 8978068
43. Homoplasmic MELAS A3243G mtDNA mutation in a colon cancer sample. A Lorenc J Bryk P Golik J Kupryjanczyk J Ostrowski M Pronicki A Semczuk M Szolkowska E Bartnik, Mitochondrion 2003 3 2 119 124 10.1016/S1567-7249(03) 00106-5 16120350
44. [Study on the mitochondrion DNA mutation in tumor tissues of gynecologic oncology patients]. HX Li S Zhong CH Li, Zhonghua Fu Chan Ke Za Zhi 2003 38 5 290 293 12895314
45. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. VW Liu HH Shi AN Cheung PM Chiu TW Leung P Nagley LC Wong HY Ngan, Cancer Res 2001 61 16 5998 6001 11507041
46. Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. L Xu Y Hu B Chen W Tang X Han H Yu C Xiao, Int J Gynecol Cancer 2006 16 4 1661 1667 10.1111/j.1525-1438.2006.00641.x 16884381
47. Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. P Parrella D Seripa MG Matera C Rabitti M Rinaldi P Mazzarelli C Gravina M Gallucci V Altomare G Flammia, et al. Cancer Lett 2003 190 1 73 77 10.1016/S0304-3835(02)00578-5 12536079
48. Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer. VW Liu Y Wang HJ Yang PC Tsang TY Ng LC Wong P Nagley HY Ngan, Hum Mutat 2003 22 2 173 174 10.1002/humu.10244 12872259
49. High frequency of mitochondrial genome instability in human endometrial carcinomas. VW Liu HJ Yang Y Wang PC Tsang AN Cheung PM Chiu TY Ng LC Wong P Nagley HY Ngan, Br J Cancer 2003 89 4 697 701 10.1038/sj.bjc.6601110 12915881
50. Microsatellite instability in mitochondrial genome of common female cancers. Y Wang VW Liu PC Tsang PM Chiu AN Cheung US Khoo P Nagley HY Ngan, Int J Gynecol Cancer 2006 16 Suppl 1 259 266 10.1111/j.1525-1438.2006.00412.x 16515601
51. Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations. A Semczuk A Lorenc L Putowski K Futyma J Bryk P Miotla E Bartnik, Oncol Rep 2006 16 5 1041 1045 17016590
52. Mutational dynamics in human tumors confirm the neutral intrinsic instability of the mitochondrial D-loop poly-cytidine repeat. S Schwartz Jr H Alazzouzi M Perucho, Genes Chromosomes Cancer 2006 45 8 770 780 10.1002/gcc.20340 16708351
53. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. A Alonso P Martin C Albarran B Aquilera O Garcia A Guzman H Oliva M Sancho, Electrophoresis 1997 18 5 682 685 10.1002/elps.1150180504 9194590
54. Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus. F Miyazono PM Schneider R Metzger U Warnecke-Eberz SE Baldus HP Dienes T Aikou AH Hoelscher, Oncogene 2002 21 23 3780 3783 10.1038/sj.onc.1205532 12032845
55. Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. M Gomez-Zaera J Abril L Gonzalez F Aguilo E Condom M Nadal V Nunes, Mutat Res 2006 595 1-2 42 51 16472830
56. A practical guide to mitochondrial DNA error prevention in clinical, forensic, and population genetics. A Salas A Carracedo V Macaulay M Richards HJ Bandelt, Biochem Biophys Res Commun 2005 335 3 891 899 10.1016/j.bbrc.2005.07. 161 16102729
57. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. V Maximo P Soares J Lima J Cameselle-Teijeiro M Sobrinho-Simoes, Am J Pathol 2002 160 5 1857 1865 12000737
58. What is a 'novel' mtDNA mutation - and does 'novelty' really matter? HJ Bandelt A Salas CM Bravi, J Hum Genet 2006 51 12 1073 1082 10.1007/s10038-006- 0066-5 17021933
59. Association studies on human mitochondrial DNA: methodological aspects and results in the most common age-related diseases. N Raule F Sevini A Santoro S Altilia C Franceschi, Mitochondrion 2007 7 1-2 29 38 10.1016/j.mito.2006.11. 013 17306632
60. Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. K Hibi H Nakayama T Yamazaki T Takase M Taguchi Y Kasai K Ito S Akiyama A Nakao, Int J Cancer 2001 94 3 429 431 10.1002/ijc.1480 11745425
61. Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma. T Pejovic D Ladner M Intengan K Zheng T Fairchild D Dillon S Easley D Marchetti P Schwartz S Lele, et al. Eur J Cancer 2004 40 16 2519 2524 10.1016/j.ejca.2004.07.009 15519528
62. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. HC Lee SH Li JC Lin CC Wu DC Yeh YH Wei, Mutat Res 2004 547 1-2 71 78 15013701
63. Mitochondrial DNA copy number changes in human gliomas. BC Liang L Hays, Cancer Lett 1996 105 2 167 173 10.1016/0304-3835(96)04276-0 8697440
64. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. H Simonnet N Alazard K Pfeiffer C Gallou C Beroud J Demont R Bouvier H Schagger C Godinot, Carcinogenesis 2002 23 5 759 768 10.1093/carcin/23.5.759 12016148
65. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. M Yu Y Zhou Y Shi L Ning Y Yang X Wei N Zhang X Hao R Niu, IUBMB Life 2007 59 7 450 457 10.1080/15216540701509955 17654121
66. RNA-DNA hybrid formation at the human mitochondrial heavy-strand origin ceases at replication start sites: an implication for RNA-DNA hybrids serving as primers. B Xu DA Clayton, EMBO J 1996 15 12 3135 3143 8670814
67. Frequent occurrence of mitochondrial microsatellite instability in the D-loop region of human cancers. Y Wang VW Liu HY Ngan P Nagley, Ann N Y Acad Sci 2005 1042 123 129 10.1196/annals.1338.012 15965053
68. Conserved sequence box II directs transcription termination and primer formation in mitochondria. XH Pham G Farge Y Shi M Gaspari CM Gustafsson M Falkenberg, J Biol Chem 2006 281 34 24647 24652 10.1074/jbc.M602429200 16790426
69. Association of mitochondrial DNA displacement loop (CA)n dinucleotide repeat polymorphism with breast cancer risk and survival among Chinese women. C Ye YT Gao W Wen JP Breyer XO Shu JR Smith W Zheng Q Cai, Cancer Epidemiol Biomarkers Prev 2008 17 8 2117 2122 10.1158/1055-9965.EPI-07-2798 18708405
70. Role of the mitochondrial DNA 16184-16193 poly-C tract in type 2 diabetes. PF Chinnery HR Elliott S Patel C Lambert SM Keers SE Durham MI McCarthy GA Hitman AT Hattersley M Walker, Lancet 2005 366 9497 1650 1651 10.1016/S0140-6736(05)67492-2 16271646
71. Replication and transcription of mammalian mitochondrial DNA. P Fernandez-Silva JA Enriquez J Montoya, Exp Physiol 2003 88 1 41 56 10.1113/eph8802514 12525854
72. Frequent mutations in the mitochondrial control region DNA in breast tissue. D Rosson AA Keshgegian, Cancer Lett 2004 215 1 89 94 10.1016/j.canlet.2004.04.030 15374637
73. Analysis of the complete human mtDNA genome: methodology and inferences for human evolution. M Ingman U Gyllensten, J Hered 2001 92 6 454 461 10.1093/jhered/92.6.454 11948211
74. Mitochondrial tRNA sequences as unusual replication origins: pathogenic implications for Homo sapiens. H Seligmann NM Krishnan BJ Rao, J Theor Biol 2006 243 3 375 385 10.1016/j.jtbi.2006.06.028 16905154
75. Analysis of phylogenetically reconstructed mutational spectra in human mitochondrial DNA control region. BA Malyarchuk IB Rogozin VB Berikov MV Derenko, Hum Genet 2002 111 1 46 53 10.1007/s00439-002-0740-4 12136235
76. A critical reassessment of the role of mitochondria in tumorigenesis. A Salas YG Yao V Macaulay A Vega A Carracedo HJ Bandelt, PLoS Med 2005 2 11 296 10.1371/journal.pmed.0020296 16187796
77. Extended guidelines for mtDNA typing of population data in forensic science. W Parson HJ Bandelt, Forensic Sci Int Genet 2007 1 1 13 19 10.1016/j.fsigen.2006.11.003 19083723
78. High penetrance of sequencing errors and interpretative shortcomings in mtDNA sequence analysis of LHON patients. HJ Bandelt YG Yao A Salas T Kivisild CM Bravi, Biochem Biophys Res Commun 2007 352 2 283 291 10.1016/j.bbrc.2006.10. 131 17123466
79. The fingerprint of phantom mutations in mitochondrial DNA data. HJ Bandelt L Quintana-Murci A Salas V Macaulay, Am J Hum Genet 2002 71 5 1150 1160 10.1086/344397 12384858
80. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. JM van der Walt KK Nicodemus ER Martin WK Scott MA Nance RL Watts JP Hubble JL Haines WC Koller K Lyons, et al. Am J Hum Genet 2003 72 4 804 811 10.1086/373937 12618962
81. Mitochondrial DNA mutations in cancer. S Zanssen EA Schon, PLoS Med 2005 2 11 401 10.1371/journal.pmed.0020401 16288567
82. Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? M Mancuso FL Conforti A Rocchi A Tessitore M Muglia G Tedeschi D Panza M Monsurro P Sola J Mandrioli, et al. Neurosci Lett 2004 371 2-3 158 162 10.1016/j.neulet.2004.08.060 15519748
83. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. JM van der Walt YA Dementieva ER Martin WK Scott KK Nicodemus CC Kroner KA Welsh-Bohmer AM Saunders AD Roses GW Small, et al. Neurosci Lett 2004 365 1 28 32 10.1016/j.neulet.2004.04.051 15234467
84. Mitochondrial genetic background modifies breast cancer risk. RK Bai SM Leal D Covarrubias A Liu LJ Wong, Cancer Res 2007 67 10 4687 4694 10.1158/0008-5472.CAN-06-3554 17510395
85. Control region mtDNA variants: longevity, climatic adaptation, and a forensic conundrum. PE Coskun E Ruiz-Pesini DC Wallace, Proc Natl Acad Sci USA 2003 100 5 2174 2176 10.1073/pnas.0630589100 12606714
86. Mitochondrial DNA and survival after sepsis: a prospective study. SV Baudouin D Saunders W Tiangyou JL Elson J Poynter A Pyle S Keers DM Turnbull N Howell PF Chinnery, Lancet 2005 366 9503 2118 2121 10.1016/S0140-6736(05)67890-7 16360789
87. Mitochondrial DNA 3644T - >C mutation associated with bipolar disorder. K Munakata M Tanaka K Mori S Washizuka M Yoneda O Tajima T Akiyama S Nanko H Kunugi K Tadokoro, et al. Genomics 2004 84 6 1041 1050 10.1016/j.ygeno.2004.08.015 15533721
88. The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup J. MD Brown E Starikovskaya O Derbeneva S Hosseini JC Allen IE Mikhailovskaya RI Sukernik DC Wallace, Hum Genet 2002 110 2 130 138 10.1007/s00439-001-0660-8 11935318
89. Analysis of potential cancer biomarkers in mitochondrial DNA. JP Jakupciak GD Dakubo S Maragh RL Parr, Curr Opin Mol Ther 2006 8 6 500 506 17243485
90. Utilization of polymerase chain reaction technology in the detection of solid tumors. GV Raj JG Moreno LG Gomella, Cancer 1998 82 8 1419 1442 10.1002/(SICI)1097-0142(19980415)82:8<1419::AID-CNCR1>3.0.CO;2-4 9554517
91. Preoperative evaluation and staging of endometrial cancer. JJ Mikuta, Cancer 1995 76 10 Suppl 2041 2043 10.1002/1097-0142(19951115)76:10+<2041:: AID-CNCR2820761322>3.0.CO;2-Z 8634997
92. World Health Organisation Classification of Tumours: Pathology and genetics of tumours of the breast and female genital organs. FA Tavassoli P Devilee, IARCPress-WHO 2003
93. Mitochondrial DNA variability in Poles and Russians. BA Malyarchuk T Grzybowski MV Derenko J Czarny M Wozniak D Miscicka-Sliwka, Ann Hum Genet 2002 66 Pt 4 261 283 10.1046/j.1469-1809.2002.00116.x 12418968
94. Multiplex primer extension analysis for rapid detection of major European mitochondrial haplogroups. M Wiesbauer D Meierhofer JA Mayr W Sperl B Paulweber B Kofler, Electrophoresis 2006 27 19 3864 3868 10.1002/elps.200600086 16960846
95. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. JD Thompson DG Higgins TJ Gibson, Nucleic Acids Res 1994 22 22 4673 4680 10.1093/nar/22.22.4673 7984417
96. Handbook of parametric and nonparametric statistical procedures. DJ Sheskin, Boca Raton, FL: Chapman & Hall 4 2007
97. Statistical Methods for Rates & Proportions. JL Fleiss B Levin M Cho Paik J Fleiss, San Francisco, CA: Wiley-Interscience Inc 3 2003
98. Fundamentals of Biostatistics. B Rosner, Florence, KY: Duxbury Press 6 2005